Home
About Us
Overview
Business Model
Milestones
Our Presence
Board of Directors
Mission, Vision and Values
Environment
Products
Research & Development
Product Development
R & D Capabilities
Infrastructure
Capacities and Capabilities
Regulatory Approvals
Investor Relations
Overview
Financial Highlights
Annual Report
Code of Conduct
Shareholding Pattern
Recent News
Contact Us
Sales Offices
Enquiry Form
FAQs
Investor Relations
Overview
Financial Highlights
Annual Report
Code of Conduct
Shareholding Pattern
Recent News
Contact
Granules Investor Enquiry
E-mail:
vijay.ramanavarapu@granulesindia.com
investorrelations@granulesindia.com
Recent News
Granules India Posts Record Revenue for a Quarter: Net Revenue of Rs. 122.40 Cr. Posted for Q3 FY’10
Granules Posts Record Revenue, Net Profit Increases 121%
Granules donates 10 Lakhs to CM Relief Fund
Granules bags the coveted “Fastest Emerging Company from India” Award
Granules Signs Material Finished Dosage Contract
Granules India posts high profits in Q1 FY'10- Net profit up by 129%
Granules India Q2 FY08 Net sales up 5.44 per cent at Rs 53 crore
Granules India Limited Posts an increase of 37% in TURNOVER and 35% on NET PROFITS
PharmaMatch B.V., and Granules India Limited are pleased to announce the signing of a Memorandum of Understanding.
Granules India achieves higher EBITDA.
Granules India FY07 Net Profit up 14.61 per cent at Rs 10.59 crs.
Granules India invites shareholders approval for IFC investment.
Granules India Ltd., is pleased to announce the approval of its facilities in the recently conducted audit by US FDA.
HERITAGE and GRANULES enter Into Strategic Alliance for the Development, Supply and Marketing.